The stress of the SARS-CoV-2 virus pandemic and pro-health behaviors among medical personnel - preliminary report. / Stres okresu pandemii wirusa SARS-CoV-2 a zachowania prozdrowotne wsród personelu medycznego - doniesienie wstepne.

OBJECTIVES: The aim of the study was to evaluate pro-health behaviors as protective measures against symptoms of anxiety and depression in a group of health care workers during the first wave of the SARS-CoV-2 virus pandemic. METHODS: The group of 114 people participated in the study, including 46 medical doctors aged 41.10 ± 11.89 and 68 nurses aged 48.16 ± 8.54 years.The following scales were used for the research: the Health Behavior Inventory (HBI), the Beck Depression Inventory (BDI) and the State-Trait Anxiety Inventory (STAI). RESULTS: Taking into consideration health behaviors, an average score of 79.61 ± 13.08 points in HBI was obtained. In the BDI questionnaire, the respondents obtained an average of 3.7 ± 4.65 points. In the STAI questionnaire, in the part related to state anxiety, the mean result in the study group was 38.08 ± 9.46 points, and for trait anxiety 38.35 ± 8.44 points. Taking into account the components of HBI, only the results obtained in the subscales: positive mental attitude (PMA) and pro-health activities (PhA) correlated negatively with the results obtained in the STAI and BDI scales. Moreover, the pro-health effect of PMA on the symptoms of anxiety and depression was observed. CONCLUSIONS: No significant intensification of anxiety and depression symptoms was observed among medical personnel during the first wave of the pandemic. Health-promoting behaviors, and especially positive mental attitudes, may play a protective role in relation to the symptoms of anxiety and depression in a stressful situations.

SARS-CoV-2 Antibody Screening in Healthcare Workers in Non-Infectious Hospitals in Two Different Regions of Southern Poland (Upper Silesia and Opole Voivodeships): A Prospective Cohort Study.

(1) Background: Detection of asymptomatic or subclinical human coronavirus SARS-CoV-2 infection in healthcare workers (HCWs) is crucial for understanding the overall prevalence of the new coronavirus and its infection potential in public (non-infectious) healthcare units with emergency wards. (2) Methods: We evaluated the host serologic responses, measured with semi-quantitative ELISA tests (IgA, IgG, IgM abs) in sera of 90 individuals in Hospital no. 4 in Bytom, 84 HCWs in the University Hospital in Opole and 25 in a Miasteczko Slaskie local surgery. All volunteers had negative RT-PCR test results or had not had the RT-PCR test performed within 30 days before sampling. The ELISA test was made at two different time points (July/August 2020) with a 2-weeks gap between blood collections to avoid the "serological window" period. (3) Results: The IgG seropositivity of asymptomatic HCWs varied between 1.2% to 10% (Opole vs. Bytom, p < 0.05; all without any symptoms). IgA seropositivity in HCWs was 8.8% in Opole and 7.14% in Bytom. IgM positive levels in HCWs in Opole and Bytom was 1.11% vs. 2.38%, respectively. Individuals with IgA and IgM seropositivity results were observed only in Opole (1.19%). More studies are needed to determine whether these results are generalizable to other populations and geographic as well as socio-demographic locations. (4) Conclusions: 100% of IgG(+) volunteers were free from any symptoms of infection in the 30 days before first or second blood collection and they had no awareness of SARS-CoV-2 infection. Asymptomatic HCWs could spread SARS-CoV-2 infection to other employees and patients. Only regular HCWs RT-PCR testing can reduce the risk of SARS-CoV-2 spreading in a hospital environment. The benefit of combining the detection of specific IgA with that of combined specific IgM/IgG is still uncertain.

Novel diagnostic ELISA test for discrimination between infections with Yersinia enterocolitica and Yersinia pseudotuberculosis.

Yersiniosis is a foodborne infection caused by Yersinia enterocolitica or Yersinia pseudotuberculosis. Although yersiniosis is most often self-limiting, some patients develop chronic infections, such as reactive arthritis, glomerulonephritis, or myocarditis, which require an antibiotic treatment. Whereas early infections can be diagnosed by direct detection of bacteria, chronic infections can only be identified by serological tests. At this point, a serological method for differentiation between infections with the two Yersinia species is important since antibiotic susceptibility of these bacteria is different. Traditional immunoassays do not distinguish between infections with Y. enterocolitica and Y. pseudotuberculosis. The only test that allows for this differentiation is Mikrogen's strip test where discrimination between the two types of infection is based on two recombinant bacterial proteins, MyfA and PsaA (specific for Y. enterocolitica and Y. pseudotuberculosis, respectively). Here, we show that Y. enterocolitica and Y. pseudotuberculosis, cultured under the conditions that mimic the natural rout of infection, express surface antigens different from MyfA and PsaA that can also be used in a discrimination test. Further, we describe a new ELISA that is based on the whole bacteria and recombinant MyfA and PsaA as antigens, and that allows the differentiation between infections with Y. enterocolitica and Y. pseudotuberculosis and simultaneous detection of yersiniosis.